Found: 14
Select item for more details and to access through your institution.
Kill your darlings: Stop using the terms retrospective and prospective.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 4, p. 506, doi. 10.1002/pds.5598
- By:
- Publication type:
- Article
Impact of direct‐acting antiviral treatment for hepatitis C on cardiovascular diseases and extrahepatic cancers.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 4, p. 486, doi. 10.1002/pds.5576
- By:
- Publication type:
- Article
Potentially inappropriate medications in nursing homes and the community older adults using the French health insurance databases.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 4, p. 475, doi. 10.1002/pds.5575
- By:
- Publication type:
- Article
Validation of claims‐based algorithms to identify non‐live birth outcomes.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 4, p. 468, doi. 10.1002/pds.5574
- By:
- Publication type:
- Article
Impact of lifestyle and socioeconomic position on use of non‐steroidal anti‐inflammatory drugs: A population‐based cohort study.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 4, p. 455, doi. 10.1002/pds.5571
- By:
- Publication type:
- Article
Longitudinal effects of using and discontinuing central nervous system medications on cognitive functioning.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 4, p. 446, doi. 10.1002/pds.5569
- By:
- Publication type:
- Article
Effectiveness research in oncology with electronic health record data: A retrospective cohort study emulating the PALOMA‐2 trial.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 4, p. 426, doi. 10.1002/pds.5565
- By:
- Publication type:
- Article
Off‐label low dose amitriptyline for insomnia disorder: Patient‐reported outcomes.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 4, p. 435, doi. 10.1002/pds.5561
- By:
- Publication type:
- Article
Detection of drug safety signal of drug‐induced neutropenia and agranulocytosis in all‐aged patients using electronic medical records.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 4, p. 416, doi. 10.1002/pds.5559
- By:
- Publication type:
- Article
Exposure to nitrosatable drugs during pregnancy and childhood cancer: A matched case–control study in Denmark, 1996–2016.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 4, p. 496, doi. 10.1002/pds.5557
- By:
- Publication type:
- Article
Examining the potential direct cardiovascular benefit of tumor‐necrosis factor inhibitor in rheumatoid arthritis: Natural and controlled direct effect analyses.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 4, p. 407, doi. 10.1002/pds.5546
- By:
- Publication type:
- Article
Effect of tramadol and DOACs with special attention to dabigatran on concomitant use, on the risk of mayor bleeding using BIFAP database in Spain.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 4, p. 397, doi. 10.1002/pds.5525
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 4, p. 508, doi. 10.1002/pds.5460
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 4, p. 1, doi. 10.1002/pds.5459
- Publication type:
- Article